List Price: $219
Credits: 6.0 CMLE
Course Directors:
Tsieh Sun, MD, FASCP
Director of Hematology and Flow Cytometry, Veterans Affairs Medical Center
Professor of Pathology, University of Colorado School of Medicine, Denver, CO

Mary Lowery Nordberg, PhD
Director of Molecular Pathology and Cancer Cytogenetics
Assistant Professor of Pathology and Pediatrics, Louisiana State University Health Sciences Center & Feist-Weiller Cancer Center, Shreveport, LA

Attend this workshop to learn the latest advances in this crucial laboratory area. You’ll hear a discussion of the increasingly important role flow cytometry plays in the therapeutic monitoring of hematologic neoplasms. Plus, you’ll explore the applications of four-color antibody panels, gene products, anti-T-cell receptor and other new antibodies, and cytoplasmic and nuclear stains. Because certain ancillary tests are needed to provide optimum testing and to comply with the WHO classification requirements regarding diseases such as chronic myelogenous leukemia and Burkitt lymphoma, you’ll learn how tests such as cytogenetic karyotype, fluorescence in situ hybridization [FISH] and polymerase chain reaction [PCR] complement flow cytometry in the management of leukemia and lymphoma patients. An introduction to newer techniques, such as the real-time PCR (TaqMan PCR), microarrays, and laser-capture dissection, will be included.

Following this workshop, you will be able to:

• Describe recent advances in flow cytometry and molecular genetics
• Discuss appropriate tests for the diagnosis and prognostic prediction of different hematologic neoplasms
• Interpret results obtained from reference laboratories